发明名称 |
Screening for a CD45 point mutation which indicates altered immunological function |
摘要 |
A method of screening a human subject for an altered immune response capability which comprises screening the CD45 gene (PTPCR gene) for the presence or absence of a A to G single nucleotide polymorphism (SNP) at position 138 (A138G) of exon 6 which produces a threonine to alanine amino acid substitution at position 47 of exon 6 (Thr47Ala; T47A). The mutation produces altered patterns of CD45 mRNA and protein isoform expression. The presence of the mutant allele indicates a more vigorous response to infection by pathogens, for example hepatitis B virus (HBV) and absence of the mutation indicates who reduced susceptibility to autoimmune disease, for example Graves disease or Hashimoto's thyroiditis. The point mutation is more common in Mongoloid races and is preferably screened for using ARMS PCR. A set of PCR primers are also claimed. |
申请公布号 |
GB2399882(A) |
申请公布日期 |
2004.09.29 |
申请号 |
GB20030022393 |
申请日期 |
2003.09.24 |
申请人 |
* THE EDWARD JENNER INSTITUTE FOR VACCINE RESEARCH |
发明人 |
PETER C L * BEVERLEY;ELMA Z * TCHILIAN;TARA * STANTON |
分类号 |
C12Q1/68;(IPC1-7):C12Q1/68;C12N15/11 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|